About this trial
The aim is to provide effective preoperative analgesia in patients undergoing surgical procedures due to hip fractures by administering a pericapsular nerve group (PENG) block under ultrasound guidance. This approach seeks to increase patient satisfaction, reduce analgesic requirements, enable earlier discharge, and decrease morbidity and mortality.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing hip farcture surgery
Disqualifiers
Chronic analgesics consumption
Patients contraindicated for neuraxial anesthesia
Alcohol and drug addiction
Allergies to local anesthetics and opioids
Trial design
Parallel
Treatments tested in this trial
PENG block with 0.25% bupivacaine guided by ultrasound.
Procedure/SurgeryPENG (Pericapsular nerve block) is a peripheral nerve block which is performed for patients with hip fractures aimed to prevent preoperative and postoperative pain. It is performed under sterile conditions under ultrasound guideance.
Treatment groups
Trial outcomes
Primary outcomes
Preoperative Pain Scores and Opioid Consumption
Preoperative pain of patients will be assessed with NRS (Numeric Raitng Scale) which ranges from 0 (no pain) to 10 (the most severe pain imaginable).
Secondary outcomes
Discharge Time
Postoperative Mortality and Morbidity
Postoperative complications such as infections, embolism, chronic pain and survival status
Opioid Consumption
Opioid consumption will be assessed with patient controlled analgesia (PCA) device which measures analgesic drug consumption. Fentanyl consumption unit will be micrograms.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: